Navigation Links
Allied Healthcare Products Reports Modest Profit for Quarter
Date:2/8/2011

ST. LOUIS, Feb. 8, 2011 /PRNewswire/ -- With its governmental markets still depressed, Allied Healthcare Products (Nasdaq: AHPI) earned a modest profit in the second quarter of fiscal year 2011 and improvement in its year-over-year performance.

Net income for the quarter ending December 31 was $117,000, or 1 cent per basic and diluted share, compared to $22,000, or zero cents per share, for the previous year's quarter. For the first two quarters of the fiscal year, net income was about $29,000, or zero cents per basic and diluted share, compared to a loss of $723,000, or a negative 9 cents per share, for the previous year's first two quarters. Allied earnings in the previous year were affected by a non-cash charge of $609,000 for a grant of stock options.

Sales for the second quarter totaled about $11.4 million, slightly below the mark set in the previous year's quarter. For the first six months of the fiscal year, sales increased by about $605,000, or 2.7 percent, to about $23.3 million.

Unanticipated costs of about $280,000 associated with the introduction of a new product depressed results for the quarter. Most of those costs were a one-time event.

In the first half of the fiscal year, prices for commodity materials such as brass and steel increased 8 percent. Still, Allied managed to hold overall purchased material costs to an increase of less than 1 percent. Also, the company reduced selling, general and administrative (SG&A) costs by about 10 percent for the quarter, the second consecutive quarter in which significant SG&A reductions were achieved."Our cost structure is strong, so we are well-positioned to take advantage of an upturn in the market," said Earl Refsland, Allied president and chief executive officer.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical product dealers.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements."  Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.ALLIED HEALTHCARE PRODUCTS, INC.CONSOLIDATED STATEMENT OF OPERATIONS(UNAUDITED)Three months ended,Six months ended,December 31,December 31,2010200920102009Net sales

$11,402,681$11,414,908$23,343,414$22,738,584Cost of sales

8,592,7128,470,16917,982,71817,390,969Gross profit

2,809,9692,944,7395,360,6965,347,615Selling General and administrative expenses

2,600,7342,900,1135,285,3106,491,891Income (loss) from operations

209,23544,62675,386(1,144,276)Interest income

(8,067)(464)(15,542)(1,448)Interest expense

-162662,574Other, net

28,41011,78543,50922,79820,34311,48328,03323,924Income (loss) before provision for(benefit from) income taxes

188,89233,14347,353(1,168,200)Provision for (benefit from) income taxes

71,77911,57317,994(444,832)Net income (loss)

$117,113$21,570$29,359($723,368)Net income (loss) per share - Basic

$0.01$0.00$0.00($0.09)Net income (loss) per share - Diluted

$0.01$0.00$0.00($0.09)Weighted average common shares outstanding - Basic

8,098,3668,092,7348,095,8768,040,528Weighted average common shares outstanding - Diluted

8,119,3868,217,1038,114,7248,040,528ALLIED HEALTHCARE PRODUCTS, INC.CONSOLIDATED BALANCE SHEET(UNAUDITED)December 31, 2010June 30, 2010ASSETSCurrent assets:Cash and cash equivalents

$6,239,426$5,263,324Accounts receivable, net of allowances  of $300,000

4,224,9755,418,253Inventories, net

11,423,93311,155,456Income tax receivable

811,347877,665Other current assets

237,635221,840Total current assets

22,937,31622,936,538Property, plant and equipment, net

9,015,1079,661,395Other assets, net

326,961333,084Total assets

$32,279,384$32,931,017LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
2,123,410$   1,950,446Other accrued liabilities

1,653,5192,241,259Deferred income taxes

425,036429,699Deferred revenue

688,200688,200Total current liabilities

4,890,1655,309,604Deferred revenue458,800802,900Commitments and contingenciesStockholders' equity:Preferred stock; $0.01 par value; 1,500,000 shares  authorized; no shares issued and outstanding

--Series A preferred stock; $0.01 par value; 200,000 shares  authorized; no shares issued and outstanding

--Common stock; $0.01 par value; 30,000,000 shares  authorized; 10,415,709 and 10,396,878  shares issued  at December 31, 2010 and June 30, 2010, respectively;  8,112,217 and 8,093,386 shares outstanding at  December 31, 2010 and June 30, 2010, respectively

104,157103,969Additional paid-in capital

48,445,28148,362,922Accumulated deficit

(887,591)(916,950)Less treasury stock, at cost; 2,303,492 shares at   December 31, 2010 and June 30, 2010, respectively

(20,731,428)(20,731,428)Total stockholders' equity

26,930,41926,818,513Total liabilities and stockholders' equity

$32,279,384$32,931,017
'/>"/>

SOURCE Allied Healthcare Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Recession Continues to Depress Sales at Allied Healthcare Products
2. Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions
3. Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia
4. Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010
5. Allied Telesis, Hosted PACS Solutions Join Forces to Deliver Managed Cloud-Based Picture Archiving and Communications Systems (PACS) Services
6. Allied Healthcare Products Reports Narrow Loss for Quarter But Improves Year-Over-Year Performance
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. ViroPharma to Present at Three Upcoming Healthcare Conferences
10. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... ITL Limited, ( ASX: ITD ), an innovative diversified ... year ended 31 December 2016 compared with the previous corresponding period. ... viewed here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: ... 2015: $15.7m; up 11%) Profit before tax of ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 24, 2017 , ... Healthcare Associates of McKinney announced today that ... at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. It is in ... , As the practice has grown, the need for more space has been paramount. ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... Charlevoix, MI (PRWEB) , ... February 24, 2017 ... ... venue in Charlevoix, once again hosted their Military Wedding Giveaway, with the ... be hosted by Castle Farms with services generously donated from local vendors: A ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare ... audience, will be participating in Rare Disease Day events, hosted by the Rare ... Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an approved content provider for the National Institute for Health and Care ... social care-related organizations in the National Health Service (NHS) to search, order and ...
Breaking Medicine News(10 mins):